XNCR
Xencor Inc

753
Mkt Cap
$823.36M
Volume
487,644.00
52W High
$18.69
52W Low
$6.92
PE Ratio
-6.49
XNCR Fundamentals
Price
$10.82
Prev Close
$11.53
Open
$11.36
50D MA
$14.96
Beta
1.35
Avg. Volume
752,957.00
EPS (Annual)
-$3.58
P/B
1.32
Rev/Employee
$441,972.00
Loading...
Loading...
News
all
press releases
Xencor (NASDAQ:XNCR) Shares Pass Below 50-Day Moving Average - What's Next?
Xencor (NASDAQ:XNCR) Stock Crosses Below 50 Day Moving Average - What's Next...
MarketBeat·10d ago
News Placeholder
More News
News Placeholder
SG Americas Securities LLC Takes Position in Xencor, Inc. $XNCR
SG Americas Securities LLC acquired a new position in Xencor, Inc. (NASDAQ:XNCR - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission...
MarketBeat·18d ago
News Placeholder
Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Xencor, Inc. (NASDAQ:XNCR - Get Free Report) has earned an average rating of "Moderate Buy" from the ten research firms that are currently covering the stock, MarketBeat Ratings reports. One...
MarketBeat·18d ago
News Placeholder
Xencor (NASDAQ:XNCR) Shares Down 7.1% - Here's Why
Xencor (NASDAQ:XNCR) Stock Price Down 7.1% - Time to Sell...
MarketBeat·21d ago
News Placeholder
Xencor (NASDAQ:XNCR) Shares Pass Below 50-Day Moving Average - Time to Sell?
Xencor (NASDAQ:XNCR) Share Price Crosses Below 50-Day Moving Average - Here's What Happened...
MarketBeat·24d ago
News Placeholder
Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced corporate priorities and...
Business Wire·29d ago
News Placeholder
Xencor (NASDAQ:XNCR) Trading Down 7.1% - Time to Sell?
Xencor (NASDAQ:XNCR) Stock Price Down 7.1% - Should You Sell...
MarketBeat·1mo ago
News Placeholder
Xencor (NASDAQ:XNCR) VP Sells $1,153,329.24 in Stock
Xencor, Inc. (NASDAQ:XNCR - Get Free Report) VP John Desjarlais sold 73,367 shares of Xencor stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of...
MarketBeat·1mo ago
News Placeholder
Xencor (NASDAQ:XNCR) CEO Bassil Dahiyat Sells 114,377 Shares
Xencor, Inc. (NASDAQ:XNCR - Get Free Report) CEO Bassil Dahiyat sold 114,377 shares of the firm's stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $15.71...
MarketBeat·1mo ago
News Placeholder
Xencor (NASDAQ:XNCR) VP John Desjarlais Sells 73,367 Shares
Xencor, Inc. (NASDAQ:XNCR - Get Free Report) VP John Desjarlais sold 73,367 shares of the company's stock in a transaction on Friday, December 19th. The stock was sold at an average price of $15.72...
MarketBeat·1mo ago
<
1
2
...
>

Latest XNCR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.